Assessing the Neuroprotective Benefits for Babies of Antenatal Magnesium Sulphate: An Individual Participant Data Meta-Analysis
This comprehensive individual participant data meta-analysis, encompassing five randomized controlled trials with 5,493 women and 6,131 infants, evaluated the efficacy of antenatal magnesium sulphate (MgSO₄) in reducing the risk of cerebral palsy (CP) and death in preterm births. The analysis revealed that MgSO₄ administration significantly decreased the incidence of CP